The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase

Biochemical and Biophysical Research Communications

Volumn 399, Issue 2, 2010, Pages 238-244

  Terashima, Minoru ^a   Ishimura, Akihiko ^a   Yoshida, Masakazu ^a   Suzuki, Yutaka ^b   Sugano, Sumio ^b   Suzuki, Takeshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Histone demethylase; JmjC domain; Rb; Transcription; Tumor suppressor gene

Indexed keywords

PROTEIN RB12; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UTX HISTONE DEMETHYLASE;

ARTICLE; CARCINOGENESIS; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HISTONES; METHYLATION; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P130;

EID: 77955846599     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.061     Document Type: Article

References (25)

1. Bhaumik S.R., Smith E., Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 2007, 14:1008-1016.
2. Klose R.J., Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 2007, 8:307-318.
3. Cloos P.A., Christensen J., Agger K., Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 2008, 22:1115-1140.
4. Mosammaparast N., Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 2010, 79:155-179.
5. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
6. Bernstein B.E., Kamal M., Lindblad-Toh K., Bekiranov S., Bailey D.K., Huebert D.J., McMahon S., Karlsson E.K., Kulbokas E.J., Gingeras T.R., Schreiber S.L., Lander E.S. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005, 120:169-181.
7. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., Jenkins N.A., Copeland N.G. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 2002, 32:166-174.
8. Suzuki T., Minehata K., Akagi K., Jenkins N.A., Copeland N.G. Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice. EMBO J. 2006, 25:3422-3431.
9. Ishimura A., Terashima M., Kimura H., Akagi K., Suzuki Y., Sugano S., Suzuki T. Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene. Biochem. Biophys. Res. Commun. 2009, 389:366-371.
10. van Haaften G., Dalgliesh G.L., Davies H., Chen L., Bignell G., Greenman C., Edkins S., Hardy C., Futreal P.A., et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 2009, 41:521-523.
11. Dalgliesh G.L., Furge K., Greenman C., Chen L., Bignell G., Butler A., Davies H., Edkins S., Futreal P.A., et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010, 463:360-363.
12. Agger K., Cloos P.A., Christensen J., Pasini D., Rose S., Rappsilber J., Issaeva I., Canaani E., Salcini A.E., Helin K. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007, 449:731-734.
13. Lee M.G., Villa R., Trojer P., Norman J., Yan K.P., Reinberg D., Di Croce L., Shiekhattar R. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007, 318:447-450.
14. Lan F., Bayliss P.E., Rinn J.L., Whetstine J.R., Wang J.K., Chen S., Iwase S., Alpatov R., Issaeva I., Canaani E., Roberts T.M., Chang H.Y., Shi Y. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 2007, 449:689-694.
15. Hong S., Cho Y.W., Yu L.R., Yu H., Veenstra T.D., Ge K. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc. Natl. Acad. Sci. USA 2007, 104:18439-18444.
16. Issaeva I., Zonis Y., Rozovskaia T., Orlovsky K., Croce C.M., Nakamura T., Mazo A., Eisenbach L., Canaani E. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol. Cell. Biol. 2007, 27:1889-1903.
17. Kimura H., Hayashi-Takanaka Y., Goto Y., Takizawa N., Nozaki N. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct. Funct. 2008, 33:61-73.
18. Tsuchihara K., Suzuki Y., Wakaguri H., Irie T., Tanimoto K., Hashimoto S., Matsushima K., Mizushima-Sugano J., Yamashita R., Nakai K., Bentley D., Esumi H., Sugano S. Massive transcriptional start site analysis of human genes in hypoxia cells. Nucleic Acids Res. 2009, 37:2249-2263.
19. Du W., Pogoriler J. Retinoblastoma family genes. Oncogene 2006, 25:5190-5200.
20. Genovese C., Trani D., Caputi M., Claudio P.P. Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene 2006, 25:5201-5209.
21. Barradas M., Anderton E., Acosta J.C., Li S., Banito A., Rodriguez-Niedenfuhr M., Maertens G., Banck M., Zhou M.M., Walsh M.J., Peters G., Gil J. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev. 2009, 23:1177-1182.
22. Agger K., Cloos P.A., Rudkjaer L., Williams K., Andersen G., Christensen J., Helin K. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev. 2009, 23:1171-1176.
23. Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., Helin K. EZH2 is downstream of the pRB-E2F pathway essential for proliferation and amplified in cancer. EMBO J. 2003, 22:5323-5335.
24. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., Chinnaiyan A.M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002, 419:624-629.
25. Wang J.K., Tsai M.C., Poulin G., Adler A.S., Chen S., Liu H., Shi Y., Chang H.Y. The histone demethylase UTX enables RB-dependent cell fate control. Genes Dev. 2010, 24:327-332.